Literature DB >> 3098249

Effect of acetylsalicylic acid on gastric mucin viscosity, permeability to hydrogen ion, and susceptibility to pepsin.

J Sarosiek, K Mizuta, A Slomiany, B L Slomiany.   

Abstract

The effect of acetylsalicylic acid (aspirin) on peptic degradation of gastric mucin, its viscosity and the ability to retard the diffusion of hydrogen ion was investigated. The results of peptic degradation indicated that, in the absence of the drug, the rate of proteolysis was proportional to mucin concentration up to 400 micrograms and remained constant with time for up to 1 hr. Introduction of aspirin led to an enhancement in the rate of proteolysis. The apparent Km value of pepsin toward mucus glycoprotein was 8.7 X 10(-7) M in the absence of the drug and 6.9 X 10(-7) M in its presence. Viscosity measurements showed a drop in mucin viscosity following preincubation with aspirin. This decrease was concentration dependent and at a 4.0 X 10(-5) M concentration of the drug reached a value of 75%. Permeability studies revealed that preincubation with 2.0 X 10(-5) M aspirin increased the permeability of mucin to hydrogen ion by 10%, while an 18% increase was obtained with 4.0 X 10(-5) M aspirin. The results suggest that aspirin weakens the integrity of the gastric mucus layer by promoting its peptic degradation, decreasing viscosity, and reducing the ability to resist hydrogen ion penetration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098249     DOI: 10.1016/0006-2952(86)90708-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

Review 1.  Non-steroidal anti-inflammatory drugs (NSAIDs) and gastro-intestinal toxicity: current issues.

Authors:  A A Shah; D J Fitzgerald; F E Murray
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

2.  Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.

Authors:  A S Taha; R I Russell
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

3.  Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man.

Authors:  G R Lipscomb; N Wallis; G Armstrong; M J Goodman; W D Rees
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

4.  Modulations in the intestinal disaccharide hydrolases and membrane dynamics: effect of non-steroidal anti-inflammatory drugs aspirin and nimesulide.

Authors:  Naveen Kaushal; S N Sanyal
Journal:  Mol Cell Biochem       Date:  2006-07-20       Impact factor: 3.396

5.  Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance.

Authors:  T Jaworski; I Sarosiek; S Sostarich; K Roeser; M Connor; S Brotze; G Wallner; J Sarosiek
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

6.  Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders.

Authors:  T Skoczylas; I Sarosiek; S Sostarich; C McElhinney; S Durham; J Sarosiek
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

7.  Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration.

Authors:  A S Taha; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

Review 8.  Mucus production after transposition of intestinal segments into the urinary tract.

Authors:  James N'Dow; Jeffrey Pearson; David Neal
Journal:  World J Urol       Date:  2004-07-30       Impact factor: 4.226

9.  Impairment of salivary mucin production resulting in declined salivary viscosity during naproxen administration as a potential link to upper alimentary tract mucosal injury.

Authors:  Cesar J Garcia; Juan Castro-Combs; Ajoy Dias; Rodrigo Alfaro; Javier Vasallo; Marek Majewski; Tom Jaworski; Grzegorz Wallner; Jerzy Sarosiek
Journal:  Clin Transl Gastroenterol       Date:  2013-07-25       Impact factor: 4.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.